Eric J. Topol

TL;DR: Elevated baseline C-reactive protein portends heightened risk of 30-day death or myocardial infarction after coronary intervention, and combined anatomic, clinical, and inflammatory risk stratification demonstrates strong predictive utility among patients undergoing percutaneous coronary intervention and may be useful for guiding future strategies.

TL;DR: Compared with aspirin, clopidogrel therapy results in a striking reduction in the elevated risk for recurrent ischemic events seen in patients with a history of prior cardiac surgery, along with a decreased risk of bleeding.

TL;DR: It is hypothesized that statin therapy has an early beneficial effect among patients undergoing PCI, and baseline, procedural, and 6-month data of statin-treated and non–statin-treated patients were compared.

TL;DR: The 4 most important new advances in the field of interventional cardiology: platelet inhibition, prevention of restenosis, stent evolution, and angiogenesis are discussed.

TL;DR: In patients with specific at-risk variants of 2 genes in the leukotriene pathway, DG-031 led to significant and dose-dependent suppression of biomarkers that are associated with increased risk of MI events.